CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments

1.2.1.List of key players profiled in the report

1.3.Research methodology

1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope

3.1.1.Top winning strategies, 2019

3.2.Top player positioning

3.2.1.Top investment pockets

3.3.Key forces shaping vaccine industry/market
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Increase in prevalence of infectious diseases
3.4.1.2.Surge in immunization programs across the globe
3.4.1.3.Increase in R&D activities to develop new vaccine

3.4.2.Restraint

3.4.2.1.Longer timelines required for vaccine production
3.4.2.2.High cost associated with the development of vaccine

3.4.3.Opportunity

3.4.3.1.Growth opportunities in the emerging markets
3.4.3.2.Increase in healthcare spending

3.4.4.Impact Analysis

3.1.COVID-19 impact analysis on vaccine market

3.1.1.Overview
3.1.2.Impact analysis

CHAPTER 4:VACCINE MARKET, BY TECHNOLOGY

4.1.Overview

4.1.1.Market size and forecast

4.2.Recombinant & conjugate vaccine

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Inactivated vaccines

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

4.4.Live attenuated vaccines

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

4.5.Toxoid vaccines

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country

4.6.Other vaccines

4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country

CHAPTER 5:GLOBAL VACCINE MARKET, BY INDICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Pneumococcal disease

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Influenza

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.'Market size and forecast, by region
5.3.3.Market analysis, by country

5.4.Human papilloma virus

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country

5.5.Meningococcal disease

5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by region
5.5.3.Market analysis, by country

5.6.Rotavirus

5.6.1.Key market trends, growth factors, and opportunities
5.6.2.Market size and forecast, by region
5.6.3.Market analysis, by country

5.7.Varicella, measles, mumps, and rubella (MMR)

5.7.1.Key market trends, growth factors, and opportunities
5.7.2.Market size and forecast, by region
5.7.3.Market analysis, by country

5.8.Diptheria, pertussis, and tetanus (DPT)

5.8.1.Key market trends, growth factors, and opportunities
5.8.2.Market size and forecast, by region
5.8.3.Market analysis, by country

5.9.Polio

5.9.1.Key market trends, growth factors, and opportunities
5.9.2.Market size and forecast, by region
5.9.3.Market analysis, by country

5.10.Hepatitis

5.10.1.Key market trends, growth factors, and opportunities
5.10.2.Market size and forecast, by region
5.10.3.Market analysis, by country

5.11.Other indications

5.11.1.Key market trends, growth factors, and opportunities
5.11.2.Market size and forecast, by region
5.11.3.Market analysis, by country

CHAPTER 6:VACCINES MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Pediatric vaccines

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.Adult vaccines

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

6.4.Travelers vaccines

6.4.1.Market size and forecast
6.4.2.Market analysis, by country

CHAPTER 7:GLOBAL VACCINE MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country
7.2.3.Market size and forecast, by technology
7.2.4.Market size and forecast, by indication
7.2.5.Market size and forecast, by end user

7.2.5.1.U.S. market size and forecast, by technology
7.2.5.2.Market size and forecast, by indication
7.2.5.3.Market size and forecast, by end user
7.2.5.4.Mexico market size and forecast, by technology
7.2.5.5.Mexico market size and forecast, by indication
7.2.5.6.Mexico market size and forecast, by end user
7.2.5.7.Canada market size and forecast, by technology
7.2.5.8.Canada market size and forecast, by indication
7.2.5.9.Canada market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country
7.3.3.Market size and forecast, by technology
7.3.4.Market size and forecast, by indication
7.3.5.Market size and forecast, by end user

7.3.5.1.Germany market size and forecast, by technology
7.3.5.2.Germany market size and forecast, by indication
7.3.5.3.Germany market size and forecast, by end user
7.3.5.4.France market size and forecast, by technology
7.3.5.5.France market size and forecast, by indication
7.3.5.6.France market size and forecast, by end user
7.3.5.7.UK market size and forecast, by technology
7.3.5.8.UK market size and forecast, by indication
7.3.5.9.UK market size and forecast, by end user
7.3.5.10.Italy market size and forecast, by technology
7.3.5.11.Italy market size and forecast, by indication
7.3.5.12.Italy market size and forecast, by end user
7.3.5.13.Spain market size and forecast, by technology
7.3.5.14.Spain market size and forecast, by indication
7.3.5.15.Spain market size and forecast, by end user
7.3.5.16.Rest of Europe market size and forecast, by technology
7.3.5.17.Rest of Europe market size and forecast, by indication
7.3.5.18.Rest of Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.3.Market size and forecast, by technology
7.4.4.Market size and forecast, by indication
7.4.5.Market size and forecast, by end user

7.4.5.1.Japan market size and forecast, by technology
7.4.5.2.Japan market size and forecast, by indication
7.4.5.3.Japan market size and forecast, by end user
7.4.5.4.China market size and forecast, by technology
7.4.5.5.China market size and forecast, by indication
7.4.5.6.China market size and forecast, by end user
7.4.5.7.India market size and forecast, by technology
7.4.5.8.India market size and forecast, by indication
7.4.5.9.India market size and forecast, by end user
7.4.5.10.Australia market size and forecast, by technology
7.4.5.11.Australia market size and forecast, by indication
7.4.5.12.Australia market size and forecast, by end user
7.4.5.13.Rest of Asia-Pacific market size and forecast, by technology
7.4.5.14.Rest of Asia-Pacific market size and forecast, by indication
7.4.5.15.Rest of Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.3.Market size and forecast, by technology
7.5.4.Market size and forecast, by indication
7.5.5.Market size and forecast, by end user

7.5.5.1.Brazil market size and forecast, by technology
7.5.5.2.Brazil market size and forecast, by indication
7.5.5.3.Brazil market size and forecast, by end user
7.5.5.4.Saudi Arabia market size and forecast, by technology
7.5.5.5.Saudi Arabia market size and forecast, by indication
7.5.5.6.Saudi Arabia market size and forecast, by end user
7.5.5.7.South Africa market size and forecast, by technology
7.5.5.8.South Africa market size and forecast, by indication
7.5.5.9.South Africa market size and forecast, by end user
7.5.5.10.Rest of LAMEA market size and forecast, by technology
7.5.5.11.Rest of LAMEA market size and forecast, by indication
7.5.5.12.Rest of LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.AstraZeneca plc.

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Product portfolio
8.1.4.Business performance

8.2.CSL Limited

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance

8.3.Emergent BioSolutions Inc.

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.1.Key strategic moves and developments

8.4.GlaxoSmithKline plc.

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments

8.5.Johnson & Johnson

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments

8.6.MERCK & CO. INC.

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments

8.7.NOVAVAX, INC.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance

8.8.PFIZER INC.

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments

8.9.Sanofi S.A.

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments

8.10.SERUM INSTITUTE OF INDIA PVT. LTD

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio